Cybin (HELP) Retained Earnings (2021 - 2025)
Cybin (HELP) reported Retained Earnings of -$5.0 million for Q1 2025, up 97.0% on a YoY basis from -$2.6 million in Q1 2024, and up 97.72% quarter-over-quarter from -$221.0 million in Q4 2024.
Cybin (HELP) Retained Earnings (2021 - 2025) Analysis & Trends
Cybin has reported Retained Earnings for 5 years, with the latest figure at -$5.0 million in Q1 2025.
- For the quarter ending Q1 2025, Retained Earnings rose 97.0% year-over-year to -$5.0 million; the trailing twelve-month figure through Mar 2025 stood at -$5.0 million (up 97.0% YoY), and the FY2025 full-year result was -$5.2 million, up 96.9% from the prior year.
- Retained Earnings for Q1 2025 stood at -$5.0 million, up from -$221.0 million in the prior quarter.
- The five-year high for Retained Earnings was $18962.4 in Q1 2021, with the low at -$221.0 million in Q4 2024.
- Historically, Retained Earnings has averaged -$105.4 million across 5 years, with a median of -$99.0 million in 2022.
- Annual changes were most pronounced in 2022 — Retained Earnings tumbled 82.67% — and 2025, when it surged 97.0%.
- Cybin's Retained Earnings stood at -$65.5 million in 2021, then slumped by 51.2% to -$99.0 million in 2022, then slumped by 51.96% to -$150.5 million in 2023, then plunged by 46.88% to -$221.0 million in 2024, then surged by 97.72% to -$5.0 million in 2025.
- The last three Retained Earnings figures came in at -$5.0 million (Q1 2025), -$221.0 million (Q4 2024), and -$218.6 million (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -5.04 Mn |
| Dec 31, 2024 | -221.05 Mn |
| Sep 30, 2024 | -218.63 Mn |
| Jun 30, 2024 | -176.25 Mn |
| Mar 31, 2024 | -167.89 Mn |
| Dec 31, 2023 | -150.50 Mn |
| Sep 30, 2023 | -130.21 Mn |
| Jun 30, 2023 | -121.10 Mn |
| Feb 28, 2023 | -40.52 Mn |
| Dec 31, 2022 | -99.04 Mn |
| Sep 30, 2022 | -94.84 Mn |
| Dec 31, 2021 | -65.50 Mn |
| Sep 30, 2021 | -51.92 Mn |
| Jun 30, 2021 | -38.84 Mn |
| Mar 31, 2021 | 18,962.38 |